Consultation outcome

Amendments to the Human Medicines Regulations 2012

From:
Medicines and Healthcare products Regulatory Agency and Department of Health and Social Care
Published
22 September 2014
Last updated
23 January 2015 — See all updates
This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
This consultation has concluded

Read the full outcome

Amendments to Human Medicines Regulations 2012 Consultation Response

PDF, 293 KB, 16 pages

Detail of outcome

The government considers that there is a clear case for Public Health England (PHE) and the Public Health Agency in Northern Ireland (PHA) to be able to authorise Patient Group Directions (PGDs). They will then be able to issue/administer specified vaccines and medicines to pre-defined groups of patients without them having to see a doctor or dentist.

This will ensure that in the event of an incident or outbreak of infectious disease PHE and PHA staff can supply/administer vaccines and medicines.

Original consultation

Summary

Seeks views on proposals to amend the Human Medicines Regulations 2012 so that PHE can develop and authorise Patient Group Directions.

This consultation ran from
to

Consultation description

The changes to the Human Medicines Regulations 2012 will strengthen the response to outbreaks of infectious disease and other incidents by extending the use of Patient Group Directions to staff employed by Public Health England (PHE).

Documents

Consultation on the proposals for amendments to Human Medicines Regulations 2012

PDF, 267 KB, 15 pages

Annex C PHE Executive Directors Organogram

PDF, 229 KB, 1 page

Annex D MLX 388: Proposals for amendments to human medicines regulations 2012

MS Word Document, 86.3 KB

Updates to this page

Published 22 September 2014
Last updated 23 January 2015 + show all updates

  1. Added a response to the consultation on proposals to allow PHE to authorise patient group directions.

  2. First published.

Sign up for emails or print this page